Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Chemical and Biological Characteristics of .

Molecules (Basel, Switzerland)

Narangerel T, Bonikowski R, Jastrząbek K, Kunicka-Styczyńska A, Plucińska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J.
PMID: 34946654
Molecules. 2021 Dec 14;26(24). doi: 10.3390/molecules26247573.

No abstract available.

Cite
Narangerel T, Bonikowski R, Jastrząbek K, et al. Chemical and Biological Characteristics of . Molecules. 2021;26(24)doi: 10.3390/molecules26247573.
Narangerel, T., Bonikowski, R., Jastrząbek, K., Kunicka-Styczyńska, A., Plucińska, A., Śmigielski, K., Majak, I., Bartos, A., & Leszczyńska, J. (2021). Chemical and Biological Characteristics of . Molecules (Basel, Switzerland), 26(24), . https://doi.org/10.3390/molecules26247573
Narangerel, Tuya, et al. "Chemical and Biological Characteristics of ." Molecules (Basel, Switzerland) vol. 26,24 (2021). doi: https://doi.org/10.3390/molecules26247573
Narangerel T, Bonikowski R, Jastrząbek K, Kunicka-Styczyńska A, Plucińska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J. Chemical and Biological Characteristics of . Molecules. 2021 Dec 14;26(24). doi: 10.3390/molecules26247573. PMID: 34946654; PMCID: PMC8705308.
Copy Download .nbib Format: NLM
Chemical and Biological Characteristics of .

Molecules (Basel, Switzerland)

Narangerel T, Bonikowski R, Jastrząbek K, Kunicka-Styczyńska A, Plucińska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J.
PMID: 34946654
Molecules. 2021 Dec 14;26(24). doi: 10.3390/molecules26247573.

No abstract available.

Cite
Narangerel T, Bonikowski R, Jastrząbek K, et al. Chemical and Biological Characteristics of . Molecules. 2021;26(24)doi: 10.3390/molecules26247573.
Narangerel, T., Bonikowski, R., Jastrząbek, K., Kunicka-Styczyńska, A., Plucińska, A., Śmigielski, K., Majak, I., Bartos, A., & Leszczyńska, J. (2021). Chemical and Biological Characteristics of . Molecules (Basel, Switzerland), 26(24), . https://doi.org/10.3390/molecules26247573
Narangerel, Tuya, et al. "Chemical and Biological Characteristics of ." Molecules (Basel, Switzerland) vol. 26,24 (2021). doi: https://doi.org/10.3390/molecules26247573
Narangerel T, Bonikowski R, Jastrząbek K, Kunicka-Styczyńska A, Plucińska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J. Chemical and Biological Characteristics of . Molecules. 2021 Dec 14;26(24). doi: 10.3390/molecules26247573. PMID: 34946654.
Copy Download .nbib Format: NLM
[Lymphoblastic transformation tests in differential diagnosis of mediastinal tumors].

Polskie Archiwum Medycyny Wewnetrznej

Pluzańska A.
PMID: 5543787
Pol Arch Med Wewn. 1971;46(1):41-5.

No abstract available.

Cite
Pluzańska A. Próby zachowania transformacji blastycznej limfocytów w diagnostyce róznicowej guzów śrópiersia. [Lymphoblastic transformation tests in differential diagnosis of mediastinal tumors]. Pol Arch Med Wewn. 1971;46(1):41-5
Pluzańska, A. (1971). Próby zachowania transformacji blastycznej limfocytów w diagnostyce róznicowej guzów śrópiersia. [Lymphoblastic transformation tests in differential diagnosis of mediastinal tumors]. Polskie Archiwum Medycyny Wewnetrznej, 46(1), 41-5.
Pluzańska, A. "Próby zachowania transformacji blastycznej limfocytów w diagnostyce róznicowej guzów śrópiersia." [Lymphoblastic transformation tests in differential diagnosis of mediastinal tumors]. Polskie Archiwum Medycyny Wewnetrznej vol. 46,1 (1971): 41-5.
Pluzańska A. Próby zachowania transformacji blastycznej limfocytów w diagnostyce róznicowej guzów śrópiersia. [Lymphoblastic transformation tests in differential diagnosis of mediastinal tumors]. Pol Arch Med Wewn. 1971;46(1):41-5. Polish. PMID: 5543787.
Copy Download .nbib Format: NLM
Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL).

Journal of clinical medicine

Kwiatkowska J, Zuk M, Migdal A, Kusa J, Skiba E, Zygielo K, Przetocka K, Werynski P, Banaszak P, Rzeznik-Bieniaszewska A, Surmacz R, Bobkowski W, Wojcicka-Urbanska B, Werner B, Pluzanska J, Ostrowska K, Waldoch A, Kopec G.
PMID: 32503164
J Clin Med. 2020 Jun 03;9(6). doi: 10.3390/jcm9061717.

We present the results from the pediatric arm of the Polish Registry of Pulmonary Hypertension. We prospectively enrolled all pulmonary arterial hypertension (PAH) patients, between the ages of 3 months and 18 years, who had been under the care...

Cite
Kwiatkowska J, Zuk M, Migdal A, et al. Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med. 2020;9(6)doi: 10.3390/jcm9061717.
Kwiatkowska, J., Zuk, M., Migdal, A., Kusa, J., Skiba, E., Zygielo, K., Przetocka, K., Werynski, P., Banaszak, P., Rzeznik-Bieniaszewska, A., Surmacz, R., Bobkowski, W., Wojcicka-Urbanska, B., Werner, B., Pluzanska, J., Ostrowska, K., Waldoch, A., & Kopec, G. (2020). Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). Journal of clinical medicine, 9(6), . https://doi.org/10.3390/jcm9061717
Kwiatkowska, Joanna, et al. "Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)." Journal of clinical medicine vol. 9,6 (2020). doi: https://doi.org/10.3390/jcm9061717
Kwiatkowska J, Zuk M, Migdal A, Kusa J, Skiba E, Zygielo K, Przetocka K, Werynski P, Banaszak P, Rzeznik-Bieniaszewska A, Surmacz R, Bobkowski W, Wojcicka-Urbanska B, Werner B, Pluzanska J, Ostrowska K, Waldoch A, Kopec G. Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med. 2020 Jun 03;9(6). doi: 10.3390/jcm9061717. PMID: 32503164; PMCID: PMC7356296.
Copy Download .nbib Format: NLM
Chemical and Biological Characteristics of .

Molecules (Basel, Switzerland)

Narangerel T, Bonikowski R, Jastrząbek K, Kunicka-Styczyńska A, Plucińska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J.
PMID: 34946654
Molecules. 2021 Dec 14;26(24). doi: 10.3390/molecules26247573.

No abstract available.

Cite
Narangerel T, Bonikowski R, Jastrząbek K, et al. Chemical and Biological Characteristics of . Molecules. 2021;26(24)doi: 10.3390/molecules26247573.
Narangerel, T., Bonikowski, R., Jastrząbek, K., Kunicka-Styczyńska, A., Plucińska, A., Śmigielski, K., Majak, I., Bartos, A., & Leszczyńska, J. (2021). Chemical and Biological Characteristics of . Molecules (Basel, Switzerland), 26(24), . https://doi.org/10.3390/molecules26247573
Narangerel, Tuya, et al. "Chemical and Biological Characteristics of ." Molecules (Basel, Switzerland) vol. 26,24 (2021). doi: https://doi.org/10.3390/molecules26247573
Narangerel T, Bonikowski R, Jastrząbek K, Kunicka-Styczyńska A, Plucińska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J. Chemical and Biological Characteristics of . Molecules. 2021 Dec 14;26(24). doi: 10.3390/molecules26247573. PMID: 34946654.
Copy Download .nbib Format: NLM
Chemical and Biological Profile and Allergenicity of .

Antioxidants (Basel, Switzerland)

Narangerel T, Sójka M, Bonikowski R, Jastrząbek K, Sroczyński W, Plucińska A, Kunicka-Styczyńska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J.
PMID: 34943008
Antioxidants (Basel). 2021 Nov 28;10(12). doi: 10.3390/antiox10121905.

No abstract available.

Cite
Narangerel T, Sójka M, Bonikowski R, et al. Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel). 2021;10(12)doi: 10.3390/antiox10121905.
Narangerel, T., Sójka, M., Bonikowski, R., Jastrząbek, K., Sroczyński, W., Plucińska, A., Kunicka-Styczyńska, A., Śmigielski, K., Majak, I., Bartos, A., & Leszczyńska, J. (2021). Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antiox10121905
Narangerel, Tuya, et al. "Chemical and Biological Profile and Allergenicity of ." Antioxidants (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antiox10121905
Narangerel T, Sójka M, Bonikowski R, Jastrząbek K, Sroczyński W, Plucińska A, Kunicka-Styczyńska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J. Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel). 2021 Nov 28;10(12). doi: 10.3390/antiox10121905. PMID: 34943008.
Copy Download .nbib Format: NLM
Chemical and Biological Profile and Allergenicity of .

Antioxidants (Basel, Switzerland)

Narangerel T, Sójka M, Bonikowski R, Jastrząbek K, Sroczyński W, Plucińska A, Kunicka-Styczyńska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J.
PMID: 34943008
Antioxidants (Basel). 2021 Nov 28;10(12). doi: 10.3390/antiox10121905.

No abstract available.

Cite
Narangerel T, Sójka M, Bonikowski R, et al. Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel). 2021;10(12)doi: 10.3390/antiox10121905.
Narangerel, T., Sójka, M., Bonikowski, R., Jastrząbek, K., Sroczyński, W., Plucińska, A., Kunicka-Styczyńska, A., Śmigielski, K., Majak, I., Bartos, A., & Leszczyńska, J. (2021). Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antiox10121905
Narangerel, Tuya, et al. "Chemical and Biological Profile and Allergenicity of ." Antioxidants (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antiox10121905
Narangerel T, Sójka M, Bonikowski R, Jastrząbek K, Sroczyński W, Plucińska A, Kunicka-Styczyńska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J. Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel). 2021 Nov 28;10(12). doi: 10.3390/antiox10121905. PMID: 34943008; PMCID: PMC8750244.
Copy Download .nbib Format: NLM
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Paz-Ares LG, Ramalingam SS, Ciuleanu TE, Lee JS, Urban L, Caro RB, Park K, Sakai H, Ohe Y, Nishio M, Audigier-Valette C, Burgers JA, Pluzanski A, Sangha R, Gallardo C, Takeda M, Linardou H, Lupinacci L, Lee KH, Caserta C, Provencio M, Carcereny E, Otterson GA, Schenker M, Zurawski B, Alexandru A, Vergnenegre A, Raimbourg J, Feeney K, Kim SW, Borghaei H, O'Byrne KJ, Hellmann MD, Memaj A, Nathan FE, Bushong J, Tran P, Brahmer JR, Reck M.
PMID: 34648948
J Thorac Oncol. 2021 Oct 12; doi: 10.1016/j.jtho.2021.09.010. Epub 2021 Oct 12.

INTRODUCTION: In CheckMate 227, nivolumab plus ipilimumab prolonged overall survival (OS) versus chemotherapy in patients with tumor programmed death-ligand 1 (PD-L1) greater than or equal to 1% (primary end point) or less than 1% (prespecified descriptive analysis). We report...

Cite
Paz-Ares LG, Ramalingam SS, Ciuleanu TE, et al. First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial. J Thorac Oncol. 2021;doi: 10.1016/j.jtho.2021.09.010.
Paz-Ares, L. G., Ramalingam, S. S., Ciuleanu, T. E., Lee, J. S., Urban, L., Caro, R. B., Park, K., Sakai, H., Ohe, Y., Nishio, M., Audigier-Valette, C., Burgers, J. A., Pluzanski, A., Sangha, R., Gallardo, C., Takeda, M., Linardou, H., Lupinacci, L., Lee, K. H., Caserta, C., Provencio, M., Carcereny, E., Otterson, G. A., Schenker, M., Zurawski, B., Alexandru, A., Vergnenegre, A., Raimbourg, J., Feeney, K., Kim, S. W., Borghaei, H., O'Byrne, K. J., Hellmann, M. D., Memaj, A., Nathan, F. E., Bushong, J., Tran, P., Brahmer, J. R., & Reck, M. (2021). First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, . https://doi.org/10.1016/j.jtho.2021.09.010
Paz-Ares, Luis G, et al. "First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. (2021). doi: https://doi.org/10.1016/j.jtho.2021.09.010
Paz-Ares LG, Ramalingam SS, Ciuleanu TE, Lee JS, Urban L, Caro RB, Park K, Sakai H, Ohe Y, Nishio M, Audigier-Valette C, Burgers JA, Pluzanski A, Sangha R, Gallardo C, Takeda M, Linardou H, Lupinacci L, Lee KH, Caserta C, Provencio M, Carcereny E, Otterson GA, Schenker M, Zurawski B, Alexandru A, Vergnenegre A, Raimbourg J, Feeney K, Kim SW, Borghaei H, O'Byrne KJ, Hellmann MD, Memaj A, Nathan FE, Bushong J, Tran P, Brahmer JR, Reck M. First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial. J Thorac Oncol. 2021 Oct 12; doi: 10.1016/j.jtho.2021.09.010. Epub 2021 Oct 12. PMID: 34648948.
Copy Download .nbib Format: NLM
The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL).

Journal of clinical medicine

Kwiatkowska J, Meyer-Szary J, Mazurek-Kula A, Zuk M, Migdal A, Kusa J, Skiba E, Zygielo K, Przetocka K, Kordon Z, Banaszak P, Michalczyk A, Rzeznik-Bieniaszewska A, Surmacz R, Bobkowski W, Wojcicka-Urbanska B, Werner B, Pluzanska J, Ostrowska K, Bazgier M, Kopec G.
PMID: 33921526
J Clin Med. 2021 Apr 12;10(8). doi: 10.3390/jcm10081640.

The COVID-19 pandemic has impacted healthcare systems worldwide. Little is known about the impact of the pandemic on medical and psycho-social aspects of children with rare diseases such as pulmonary arterial hypertension and their parents. The study is based...

Cite
Kwiatkowska J, Meyer-Szary J, Mazurek-Kula A, et al. The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med. 2021;10(8)doi: 10.3390/jcm10081640.
Kwiatkowska, J., Meyer-Szary, J., Mazurek-Kula, A., Zuk, M., Migdal, A., Kusa, J., Skiba, E., Zygielo, K., Przetocka, K., Kordon, Z., Banaszak, P., Michalczyk, A., Rzeznik-Bieniaszewska, A., Surmacz, R., Bobkowski, W., Wojcicka-Urbanska, B., Werner, B., Pluzanska, J., Ostrowska, K., Bazgier, M., & Kopec, G. (2021). The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). Journal of clinical medicine, 10(8), . https://doi.org/10.3390/jcm10081640
Kwiatkowska, Joanna, et al. "The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)." Journal of clinical medicine vol. 10,8 (2021). doi: https://doi.org/10.3390/jcm10081640
Kwiatkowska J, Meyer-Szary J, Mazurek-Kula A, Zuk M, Migdal A, Kusa J, Skiba E, Zygielo K, Przetocka K, Kordon Z, Banaszak P, Michalczyk A, Rzeznik-Bieniaszewska A, Surmacz R, Bobkowski W, Wojcicka-Urbanska B, Werner B, Pluzanska J, Ostrowska K, Bazgier M, Kopec G. The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med. 2021 Apr 12;10(8). doi: 10.3390/jcm10081640. PMID: 33921526; PMCID: PMC8069741.
Copy Download .nbib Format: NLM
Chemical and Biological Profile and Allergenicity of .

Antioxidants (Basel, Switzerland)

Narangerel T, Sójka M, Bonikowski R, Jastrząbek K, Sroczyński W, Plucińska A, Kunicka-Styczyńska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J.
PMID: 34943008
Antioxidants (Basel). 2021 Nov 28;10(12). doi: 10.3390/antiox10121905.

No abstract available.

Cite
Narangerel T, Sójka M, Bonikowski R, et al. Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel). 2021;10(12)doi: 10.3390/antiox10121905.
Narangerel, T., Sójka, M., Bonikowski, R., Jastrząbek, K., Sroczyński, W., Plucińska, A., Kunicka-Styczyńska, A., Śmigielski, K., Majak, I., Bartos, A., & Leszczyńska, J. (2021). Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antiox10121905
Narangerel, Tuya, et al. "Chemical and Biological Profile and Allergenicity of ." Antioxidants (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antiox10121905
Narangerel T, Sójka M, Bonikowski R, Jastrząbek K, Sroczyński W, Plucińska A, Kunicka-Styczyńska A, Śmigielski K, Majak I, Bartos A, Leszczyńska J. Chemical and Biological Profile and Allergenicity of . Antioxidants (Basel). 2021 Nov 28;10(12). doi: 10.3390/antiox10121905. PMID: 34943008.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries